Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q2 2024 vs. Q1 2024
How the institutions holding Novo Nordisk A S changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 3 | 3 | 0 |
| Shares | 112.6K | 170.1K | +57.4K (+51.0%) |
| Value | $14.3M | $24.5M | +$10.2M (+71.1%) |
New holders (0)
Institutions that held Novo Nordisk A S at the end of Q2 2024 but not at the end of Q1 2024.
None.
Sold out (0)
Institutions that held Novo Nordisk A S at the end of Q1 2024 and filed for Q2 2024 without it.
None.